P95 and Julius Clinical Merge to Form Global, Science-Led CRO Delivering Integrated Clinical Development and Real-World Evidence500+ person global organization spans 25+ countries with operations across North America, Europe, Africa, Latin America, and Asia-Pacific
Julius Clinical Welcomes Bassem Saleh as Chief Executive OfficerZeist, The Netherlands, Sept. 23, 2025 (GLOBE NEWSWIRE) -- Julius Clinical, a leading clinical Contract Research Organization (CRO) with deep therapeutic expertise in CNS and Cardiometabolic diseases, is pleased to announce the appointment of Bassem Saleh as its new Chief Executive Officer.
